x

Adlai Nortye Ltd. (Nasdaq:ANL)

Health Care/Life Sciences • Pharmaceuticals
CIK 1944552
Company

Adlai Nortye Ltd. operates as a clinical-stage biopharmaceutical company focused on the development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018 and is headquartered in Hangzhou, China.

Address
Building 6 & 8
1008 Xiangwang Street
Yuhang District
Hangzhou, Zhejiang 311100
Employees
None
Stock Info
Close
$8.10
Day Range
7.25 - 7.80
52 Week Range
7.11 - 19.30
Average volume
1.49K
Short Interest
3.49K (02/15/24)
% of Float Shorted
N/A
Market Cap
$137.62M
Revenue
N/A
Net Income
-$58.72M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
N/A
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chairman & Chief Executive Officer
Yang Lu EMBA
Director
Ji Ping MD
Director
Lars E Birgerson MD, PhD
Independent Director
Shao Rong Liu MBA
Independent Director
Cai Cheguo
Independent Non-Executive Director
Ming Lun Tse
SEC filings
DateFormEvent
8 Aug, 2024 6-K
3 Jul, 2024 6-K
27 Jun, 2024 6-K
24 May, 2024 6-K
13 May, 2024 S-8
19 Apr, 2024 20-F
2 Apr, 2024 6-K
4 Mar, 2024 SC 13G
15 Feb, 2024 SC 13G
15 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
31 Jan, 2024 SC 13G
13 Oct, 2023 SC 13G
29 Sep, 2023 424B4 IPO completed
28 Sep, 2023 CERT
28 Sep, 2023 EFFECT
27 Sep, 2023 CORRESP
27 Sep, 2023 F-1/A
27 Sep, 2023 CORRESP
27 Sep, 2023 CORRESP
20 Sep, 2023 UPLOAD
12 Sep, 2023 CORRESP
12 Sep, 2023 F-1/A
18 Aug, 2023 8-A12B
16 Aug, 2023 UPLOAD
14 Aug, 2023 CORRESP
14 Aug, 2023 F-1/A
10 Aug, 2023 CORRESP
10 Aug, 2023 F-1/A
7 Aug, 2023 8-A12B
27 Jul, 2023 CORRESP
27 Jul, 2023 F-1
29 Jun, 2023 UPLOAD
22 Jun, 2023 DRSLTR
22 Jun, 2023 DRS/A
19 May, 2023 UPLOAD
11 May, 2023 DRSLTR
11 May, 2023 DRS/A
27 Apr, 2023 UPLOAD
14 Apr, 2023 DRSLTR
14 Apr, 2023 DRS/A
13 Mar, 2023 UPLOAD
27 Feb, 2023 DRSLTR
27 Feb, 2023 DRS/A
18 Jan, 2023 UPLOAD
21 Dec, 2022 DRSLTR
21 Dec, 2022 DRS
Last update:2024-03-06 12:16:15.752754

Sign Up to Subscribe